The development of cowpea mosaic virus as a potential source of novel vaccines

Intervirology. 1996;39(1-2):79-84. doi: 10.1159/000150478.

Abstract

Epitopes from human rhinovirus 14 (HRV-14) and human immunodeficiency virus type (HIV-1) have been expressed on the surface of particles of the plant virus, cowpea mosaic virus (CPMV). The chimaeras retain their ability to grow in plants and large quantities of virions can be easily purified. Immunological studies have shown that purified particles have the antigenic properties of the insert, and, in the case of the HIV-1 chimaera, can elicit the production of neutralising antibodies in mice. The chimaera containing the epitope from HRV-14 has been crystallised and the crystals shown to diffract to atomic resolution.

Publication types

  • Review

MeSH terms

  • AIDS Vaccines / biosynthesis*
  • AIDS Vaccines / immunology
  • Amino Acid Sequence
  • Comovirus / genetics*
  • Comovirus / immunology
  • Comovirus / pathogenicity
  • Comovirus / ultrastructure
  • Genetic Vectors*
  • HIV Envelope Protein gp41 / genetics
  • HIV Envelope Protein gp41 / immunology
  • HIV-1 / genetics
  • HIV-1 / immunology*
  • Humans
  • Molecular Sequence Data
  • Pisum sativum / virology
  • Rhinovirus / genetics
  • Rhinovirus / immunology*
  • Vaccines, Synthetic / biosynthesis*
  • Vaccines, Synthetic / immunology
  • Viral Proteins / genetics
  • Viral Proteins / immunology
  • Viral Vaccines / biosynthesis*
  • Viral Vaccines / immunology

Substances

  • AIDS Vaccines
  • HIV Envelope Protein gp41
  • Vaccines, Synthetic
  • Viral Proteins
  • Viral Vaccines
  • viral protein 1, rhinovirus